InspireMD, Inc.
NSPR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $110 | $68 | $7 | $22 |
| - Cash | $19 | $10 | $5 | $12 |
| + Debt | $2 | $2 | $2 | $1 |
| Enterprise Value | $94 | $60 | $4 | $11 |
| Revenue | $7 | $6 | $5 | $4 |
| % Growth | 13% | 20% | 15% | – |
| Gross Profit | $2 | $2 | $1 | $1 |
| % Margin | 21.5% | 29.1% | 21.6% | 16.8% |
| EBITDA | -$33 | -$21 | -$19 | -$15 |
| % Margin | -474% | -337% | -358.2% | -323.8% |
| Net Income | -$32 | -$20 | -$18 | -$15 |
| % Margin | -456.6% | -321% | -357.6% | -331.9% |
| EPS Diluted | -0.76 | -0.82 | -2.35 | -2.03 |
| % Growth | 7.3% | 65.1% | -15.8% | – |
| Operating Cash Flow | -$22 | -$16 | -$16 | -$13 |
| Capital Expenditures | -$1 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$23 | -$17 | -$16 | -$14 |